AbbVie Inc (NEOE:ABBV)
C$ 25.92 0.11 (0.43%) Market Cap: 457.28 Bil Enterprise Value: 549.05 Bil PE Ratio: 62.77 PB Ratio: 52.94 GF Score: 73/100

Abbvie Inc at Goldman Sachs Healthcare Conference Transcript

Jun 14, 2023 / 03:00PM GMT
Release Date Price: C$20.11 (-1.52%)
Chris Shibutani
Goldman Sachs Group, Inc., Research Division - Research Analyst

Good morning, everybody, and welcome to Wednesday, 3rd day of the 44th Annual Goldman Sachs Healthcare Conference. Congratulations to all of you who have survived, hopefully, people are getting some decent sleep, not too much drama on the news front.

My name is Chris Shibutani, along with my colleagues and the team and the Goldman research led by the pharma group by [Dan Zimet]. We are super pleased to have AbbVie here with us join in. So thank you so much on the team here presenting. We have Rob Michael, President and Vice Chair, I believe, right? Jeff Stewart, Chief Commercial Officer. And then Roopal Thakkar, who is Chief Medical Officer.

Questions & Answers

Chris Shibutani
Goldman Sachs Group, Inc., Research Division - Research Analyst

I always like to begin these things just making sure we understand who we're talking to and probably a lot of folks are pretty familiar with who you are, but a little thumbnail on sort of your professional journey, what

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot